Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 5,960.00
+40.00 (0.68%)
At close: Oct 23, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 77.16 billion as of October 23, 2026. It is the 28,949th most valuable company in the world and the 1,434th biggest in South Korea. Its market cap has increased by 10.17% in one year.
Market Cap
77.16B
Enterprise Value
63.72B
Revenue
n/a
Global Rank
Country Rank
#1,434 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 77.16B, a decrease of -31.59%. That is a compound annual growth rate of -11.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 77.16B | -36.53% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| High Tech Pharm | 99.53B |
| DongKoo Bio & Pharma | 92.21B |
| KOREA PHARMA | 91.40B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 90.55B |
| Samik Pharmaceutical Company LTD. | 84.17B |
| H.PIO | 83.64B |
| Sam-A Pharm. | 83.31B |
| Polaris AI Pharma | 75.98B |